PURPOSE: Posterior polymorphous corneal dystrophy (PPCD) is characterized by abnormal proliferation of corneal endothelial cells. It was shown that TGF-β2 present in aqueous humor (AH) could help maintaining the corneal endothelium in a G1-phase-arrest state. We wanted to determine whether the levels of this protein are changed in AH of PPCD patients. METHODS: We determined the concentrations of active TGF-β2 in the AH of 29 PPCD patients (42 samples) and 40 cadaver controls (44 samples) by ELISA. For data analysis the PPCD patients were divided based on either the molecular genetic cause of their disease as PPCD1 (37 samples), PPCD3 (1 sample) and PPCDx (not linked to a known PPCD loci, 4 samples) or on the presence (17 samples) or absence (25 samples) of secondary glaucoma or on whether they had undergone penetrating keratoplasty (PK, 32 samples) or repeated PK (rePK, 7 samples). RESULTS: The level of active TGF-β2 in the AH of all PPCD patients (mean ± SD; 386.98 ± 114.88 pg/ml) in comparison to the control group (260.95 ± 112.43 pg/ml) was significantly higher (P = 0.0001). Compared to the control group, a significantly higher level of active TGF-β2 was found in the PPCD1 (P = 0.0005) and PPCDx (P = 0.0022) groups. Among patients the levels of active TGF-β2 were not significantly affected by gender, age, secondary glaucoma or by the progression of dystrophy when one or repeated PK were performed. CONCLUSION: The levels of active TGF-β2 in the AH of PPCD patients are significantly higher than control values, and thus the increased levels of TGF-β2 could be a consequence of the PPCD phenotype and can be considered as another feature characterizing this disease.

Department of Medical Informatics and Biostatistics Institute of Computer Science Czech Academy of Sciences Prague Czech Republic

Department of Ophthalmology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

European Eye Clinic Lexum Prague Czech Republic

Laboratory of the Biology and Pathology of the Eye Institute of Inherited Metabolic Disorders 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Zobrazit více v PubMed

Krachmer JH. Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis. Trans Am Ophthalmol Soc. 1985;83:413–75. PubMed PMC

Merjava S, Liskova P, Sado Y, Davis PF, Greenhill NS, Jirsova K. Changes in the localization of collagens IV and VIII in corneas obtained from patients with posterior polymorphous corneal dystrophy. Exp Eye Res. 2009;88(5):945–52. doi: 10.1016/j.exer.2008.12.017 PubMed DOI

Davidson AE, Liskova P, Evans CJ, Dudakova L, Noskova L, Pontikos N, et al. Autosomal-Dominant Corneal Endothelial Dystrophies CHED1 and PPCD1 Are Allelic Disorders Caused by Non-coding Mutations in the Promoter of OVOL2. Am J Hum Genet. 2016;98(1):75–89. doi: 10.1016/j.ajhg.2015.11.018 PubMed DOI PMC

Biswas S, Munier FL, Yardley J, Hart-Holden N, Perveen R, Cousin P, et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 2001;10(21):2415–23. PubMed

Krafchak CM, Pawar H, Moroi SE, Sugar A, Lichter PR, Mackey DA, et al. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet. 2005;77(5):694–708. doi: 10.1086/497348 PubMed DOI PMC

Liskova P, Evans CJ, Davidson AE, Zaliova M, Dudakova L, Trkova M, et al. Heterozygous deletions at the ZEB1 locus verify haploinsufficiency as the mechanism of disease for posterior polymorphous corneal dystrophy type 3. European journal of human genetics: EJHG. 2016;24(7):985–91. PubMed Central PMCID: PMCPMC5070886. doi: 10.1038/ejhg.2015.232 PubMed DOI PMC

Evans CJ, Liskova P, Dudakova L, Hrabcikova P, Horinek A, Jirsova K, et al. Identification of six novel mutations in ZEB1 and description of the associated phenotypes in patients with posterior polymorphous corneal dystrophy 3. Annals of human genetics. 2015;79(1):1–9. doi: 10.1111/ahg.12090 PubMed DOI

Liskova P, Palos M, Hardcastle AJ, Vincent AL. Further genetic and clinical insights of posterior polymorphous corneal dystrophy 3. JAMA Ophthalmol. 2013;131(10):1296–303. doi: 10.1001/jamaophthalmol.2013.405 PubMed DOI

Liskova P, Filipec M, Merjava S, Jirsova K, Tuft SJ. Variable ocular phenotypes of posterior polymorphous corneal dystrophy caused by mutations in the ZEB1 gene. Ophthalmic Genet. 2010;31(4):230–4. doi: 10.3109/13816810.2010.518577 PubMed DOI

Liskova P, Tuft SJ, Gwilliam R, Ebenezer ND, Jirsova K, Prescott Q, et al. Novel mutations in the ZEB1 gene identified in Czech and British patients with posterior polymorphous corneal dystrophy. Hum Mutat. 2007;28(6):638. PubMed PMC

Liskova P, Gwilliam R, Filipec M, Jirsova K, Reinstein Merjava S, Deloukas P, et al. High prevalence of posterior polymorphous corneal dystrophy in the Czech Republic; linkage disequilibrium mapping and dating an ancestral mutation. PLoS One. 2012;7(9):e45495 doi: 10.1371/journal.pone.0045495 PubMed DOI PMC

Joyce NC. Proliferative capacity of corneal endothelial cells. Exp Eye Res. 2012;95(1):16–23. doi: 10.1016/j.exer.2011.08.014 PubMed DOI PMC

Enomoto K, Mimura T, Harris DL, Joyce NC. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells. Invest Ophthalmol Vis Sci. 2006;47(10):4330–40. doi: 10.1167/iovs.05-1581 PubMed DOI

Raphael B, Kerr NC, Shimizu RW, Lass JH, Crouthamel KC, Glaser SR, et al. Enhanced healing of cat corneal endothelial wounds by epidermal growth factor. Invest Ophthalmol Vis Sci. 1993;34(7):2305–12. PubMed

Schultz G, Cipolla L, Whitehouse A, Eiferman R, Woost P, Jumblatt M. Growth factors and corneal endothelial cells: III. Stimulation of adult human corneal endothelial cell mitosis in vitro by defined mitogenic agents. Cornea. 1992;11(1):20–7. PubMed

Henriquez AS, Kenyon KR, Dohlman CH, Boruchoff SA, Forstot SL, Meyer RF, et al. Morphologic characteristics of posterior polymorphous dystrophy. A study of nine corneas and review of the literature. Surv Ophthalmol. 1984;29(2):139–47. PubMed

Jirsova K, Merjava S, Martincova R, Gwilliam R, Ebenezer ND, Liskova P, et al. Immunohistochemical characterization of cytokeratins in the abnormal corneal endothelium of posterior polymorphous corneal dystrophy patients. Exp Eye Res. 2007;84(4):680–6. doi: 10.1016/j.exer.2006.12.006 PubMed DOI

Threlkeld AB, Green WR, Quigley HA, de la Cruz Z, Stark WJ. A clinicopathologic study of posterior polymorphous dystrophy:implications for pathogenetic mechanism of the associated glaucoma. Trans Am Ophthalmol Soc. 1994;92:133–65. PubMed PMC

Rodrigues MM, Sun TT, Krachmer J, Newsome D. Epithelialization of the corneal endothelium in posterior polymorphous dystrophy. Invest Ophthalmol Vis Sci. 1980;19(7):832–5. PubMed

Waring GO 3rd. Posterior collagenous layer of the cornea. Ultrastructural classification of abnormal collagenous tissue posterior to Descemet's membrane in 30 cases. Arch Ophthalmol. 1982;100(1):122–34. PubMed

Merjava S, Malinova E, Liskova P, Filipec M, Zemanova Z, Michalova K, et al. Recurrence of posterior polymorphous corneal dystrophy is caused by the overgrowth of the original diseased host endothelium. Histochem Cell Biol. 2011;136(1):93–101. doi: 10.1007/s00418-011-0830-2 PubMed DOI

Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol. 2002;118(2):211–5. doi: 10.1046/j.1523-1747.2002.01641.x PubMed DOI

Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. TGF-beta—an excellent servant but a bad master. J Transl Med. 2012;10:183 PubMed Central PMCID: PMCPMC3494542. doi: 10.1186/1479-5876-10-183 PubMed DOI PMC

Travis MA, Sheppard D. TGF-beta activation and function in immunity. Annu Rev Immunol. 2014;32:51–82. PubMed Central PMCID: PMCPMC4010192. doi: 10.1146/annurev-immunol-032713-120257 PubMed DOI PMC

Helbig H, Kittredge KL, Coca-Prados M, Davis J, Palestine AG, Nussenblatt RB. Mammalian ciliary-body epithelial cells in culture produce transforming growth factor-beta. Graefes Arch Clin Exp Ophthalmol. 1991;229(1):84–7. PubMed

Tripathi RC, Chan WF, Li J, Tripathi BJ. Trabecular cells express the TGF-beta 2 gene and secrete the cytokine. Exp Eye Res. 1994;58(5):523–8. PubMed

Maier P, Broszinski A, Heizmann U, Boehringer D, Reinhard T. Determination of active TGF-beta2 in aqueous humor prior to and following cryopreservation. Mol Vis. 2006;12:1477–82. PubMed

Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. Journal of cell science. 2003;116(Pt 2):217–24. PubMed

Joyce NC, Zieske JD. Transforming growth factor-beta receptor expression in human cornea. Invest Ophthalmol Vis Sci. 1997;38(10):1922–8. PubMed

Pasquale LR, Dorman-Pease ME, Lutty GA, Quigley HA, Jampel HD. Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci. 1993;34(1):23–30. PubMed

Nishida K, Sotozono C, Adachi W, Yamamoto S, Yokoi N, Kinoshita S. Transforming growth factor-beta 1, -beta 2 and -beta 3 mRNA expression in human cornea. Curr Eye Res. 1995;14(3):235–41. PubMed

Chen Y, Huang K, Nakatsu MN, Xue Z, Deng SX, Fan G. Identification of novel molecular markers through transcriptomic analysis in human fetal and adult corneal endothelial cells. Hum Mol Genet. 2013;22(7):1271–9. PubMed Central PMCID: PMCPMC3596846. doi: 10.1093/hmg/dds527 PubMed DOI PMC

Kim TY, Kim WI, Smith RE, Kay ED. Role of p27(Kip1) in cAMP- and TGF-beta2-mediated antiproliferation in rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci. 2001;42(13):3142–9. PubMed

Chen KH, Harris DL, Joyce NC. TGF-beta2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells. Invest Ophthalmol Vis Sci. 1999;40(11):2513–9. PubMed

Agarwal P, Daher AM, Agarwal R. Aqueous humor TGF-beta2 levels in patients with open-angle glaucoma: A meta-analysis. Mol Vis. 2015;21:612–20. PubMed Central PMCID: PMC4445076. PubMed PMC

Maier P, Broszinski A, Heizmann U, Bohringer D, Reinhardau T. Active transforming growth factor-beta2 is increased in the aqueous humor of keratoconus patients. Mol Vis. 2007;13:1198–202. PubMed

de Boer JH, Limpens J, Orengo-Nania S, de Jong PT, La Heij E, Kijlstra A. Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci. 1994;35(10):3702–10. PubMed

Maier P, Broszinski A, Heizmann U, Reinhard T. Decreased active TGF-beta2 levels in the aqueous humour during immune reactions following penetrating keratoplasty. Eye (Lond). 2008;22(4):569–75. PubMed

Cibis GW, Krachmer JA, Phelps CD, Weingeist TA. The clinical spectrum of posterior polymorphous dystrophy. Arch Ophthalmol. 1977;95(9):1529–37. PubMed

Dekaris I, Gabric N, Mazuran R, Karaman Z, Mravicic I. Profile of cytokines in aqueous humor from corneal graft recipients. Croat Med J. 2001;42(6):650–6. PubMed

R Core Team. R. Vienna, Austria: R Foundation for Statistical Computing; 2014. p. A language and environment for statistical computing. http://www.r-project.org.

Joyce NC, Harris DL, Mello DM. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Invest Ophthalmol Vis Sci. 2002;43(7):2152–9. PubMed

Joko T, Shiraishi A, Akune Y, Tokumaru S, Kobayashi T, Miyata K, et al. Involvement of P38MAPK in human corneal endothelial cell migration induced by TGF-beta(2). Exp Eye Res. 2013;108:23–32. doi: 10.1016/j.exer.2012.11.018 PubMed DOI

Wen FQ, Kohyama T, Liu X, Zhu YK, Wang H, Kim HJ, et al. Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. Am J Respir Cell Mol Biol. 2002;26(4):484–90. doi: 10.1165/ajrcmb.26.4.4784 PubMed DOI

LaGier AJ, Yoo SH, Alfonso EC, Meiners S, Fini ME. Inhibition of human corneal epithelial production of fibrotic mediator TGF-beta2 by basement membrane-like extracellular matrix. Invest Ophthalmol Vis Sci. 2007;48(3):1061–71. doi: 10.1167/iovs.06-0772 PubMed DOI

Bahrami B, Macfarlane S, Macfarlane GT. Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines. J Appl Microbiol. 2011;110(1):353–63. doi: 10.1111/j.1365-2672.2010.04889.x PubMed DOI

Roy O, Leclerc VB, Bourget JM, Theriault M, Proulx S. Understanding the process of corneal endothelial morphological change in vitro. Invest Ophthalmol Vis Sci. 2015;56(2):1228–37. doi: 10.1167/iovs.14-16166 PubMed DOI

Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, et al. TGF-beta: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst. 2014;106(2):djt369 doi: 10.1093/jnci/djt369 PubMed DOI PMC

Hayashi K, Sueishi K, Tanaka K, Inomata H. Immunohistochemical evidence of the origin of human corneal endothelial cells and keratocytes. Graefes Arch Clin Exp Ophthalmol. 1986;224(5):452–6. PubMed

Foets BJ, van den Oord JJ, Volpes R, Missotten L. In situ immunohistochemical analysis of cell adhesion molecules on human corneal endothelial cells. Br J Ophthalmol. 1992;76(4):205–9. PubMed Central PMCID: PMCPMC504228. PubMed PMC

Jirsova K, Neuwirth A, Kalasova S, Vesela V, Merjava S. Mesothelial proteins are expressed in the human cornea. Exp Eye Res. 2010;91(5):623–9. doi: 10.1016/j.exer.2010.08.002 PubMed DOI

Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, et al. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS One. 2013;8(10):e76773 PubMed Central PMCID: PMC3790720. doi: 10.1371/journal.pone.0076773 PubMed DOI PMC